Egyptian healthtech Almouneer raises $3.6 million to improve treatment of diabetes and obesity

Almouneer is a digital transformation platform offering practice management and networking solutions serving both patients and doctors in every step of the patient’s journey. Almouneer operates clinics with special focus on chronic diseases, including diabetes, fostering trust and loyalty among over 100,000 patients. Here are details of Almouneer’s latest funding round :

🚀 Launch


🏭 Industry



Rania Kadry (Cofounder)

💸 Funding & Investors

INVESTMENT (October 2023)$3.6 million (Seed)
INVESTORS (October 2023)led by Global Ventures, Proparco and Digital Africa through the Bridge Fund (FRA), Wrightwood Investments (UK) – and other international funds.

🎯 Funding purpose

Further develop DRU – Almouneer’s patient-centric platform – treating pre-diabetes, diabetes and obesity.

🌐 Country HQ

Egypt (Gizeh)

Leave a Reply

Your email address will not be published.